STOCK TITAN

Liberty Latin America (LILA) adds preferred RSUs after special dividend

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Liberty Latin America Ltd. reported that SVP, CLO and Secretary John M. Winter acquired 33,743 Restricted Share Units P tied to its Series A Preference Shares on June 17, 2026. These RSUs and his existing share appreciation rights were adjusted under anti-dilution provisions following a 0.10-share special preferred dividend with a $25 liquidation value and 9.0% fixed rate.

Positive

  • None.

Negative

  • None.
Insider WINTER JOHN M
Role SVP, CLO AND SECRETARY
Type Security Shares Price Value
Other Restricted Share Units P F1, F2 6,298 $0.00 $0.00
Other Restricted Share Units P F1, F2, F3 11,962 $0.00 $0.00
Other Restricted Share Units P F1, F2, F4 15,483 $0.00 $0.00
holding Share Appreciation Rights A F5, F6 -- -- --
holding Share Appreciation Rights C F5, F7 -- -- --
holding Share Appreciation Rights A F5, F8 -- -- --
holding Share Appreciation Rights C F5, F9 -- -- --
holding Share Appreciation Rights A F5, F10 -- -- --
holding Share Appreciation Rights C F5, F11 -- -- --
holding Share Appreciation Rights A F5, F12 -- -- --
holding Share Appreciation Rights C F5, F13 -- -- --
holding Share Appreciation Rights A F5, F14 -- -- --
holding Share Appreciation Rights C F5, F15 -- -- --
holding Share Appreciation Rights A F5, F16 -- -- --
holding Share Appreciation Rights C F5, F17 -- -- --
holding Share Appreciation Rights A F5, F18 -- -- --
holding Share Appreciation Rights C F5, F19 -- -- --
holding Share Appreciation Rights A F5, F20 -- -- --
holding Share Appreciation Rights C F5, F21 -- -- --
holding Share Appreciation Rights A F22, F23 -- -- --
holding Share Appreciation Rights C F22, F24 -- -- --
holding Share Appreciation Rights A F25, F26 -- -- --
holding Share Appreciation Rights C F25, F27 -- -- --
holding Share Appreciation Rights A F28, F29 -- -- --
holding Share Appreciation Rights C F28, F30 -- -- --
Holdings After Transaction: Restricted Share Units P — 33,743 shares (Direct); Share Appreciation Rights A — 1,112,449 shares (Direct); Share Appreciation Rights C — 2,287,135 shares (Direct)
Footnotes (30)
  1. F1. Each Restricted Share Unit P ("RSU") represents a right to receive one share of the Issuer's Series A Preference Shares at settlement.
  2. F2. In connection with the Dividend (as defined in Remarks), all RSUs with respect to the Issuer's common stock ("Original RSUs") were adjusted pursuant to the anti-dilution provisions of the incentive plans under which the RSU awards held by the reporting person were granted. Each holder of an Original RSU was entitled to receive an RSU with respect to a number of Preferred Shares equal to 0.10 multiplied by the number of shares of common stock underlying the Original RSU, subject to the same terms and conditions as the Original RSU. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3.
  3. F3. The RSUs vest in two equal annual installments on March 15 of 2027 and 2028.
  4. F4. The RSUs vest in three equal annual installments on March 15 of 2027, 2028 and 2029.
  5. F5. The derivative security is fully vested.
  6. F6. This share appreciation right award ("SAR") was previously reported as a SAR relating to 11,854 shares of the Issuer's common stock at a base price of $21.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  7. F7. This SAR was previously reported as a SAR relating to 23,708 shares of the Issuer's common stock at a base price of $21.39 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  8. F8. This SAR was previously reported as a SAR relating to 24,112 shares of the Issuer's common stock at a base price of $18.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  9. F9. This SAR was previously reported as a SAR relating to 48,224 shares of the Issuer's common stock at a base price of $18.24 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  10. F10. This SAR was previously reported as a SAR relating to 23,621 shares of the Issuer's common stock at a base price of $19.91 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  11. F11. This SAR was previously reported as a SAR relating to 47,242 shares of the Issuer's common stock at a base price of $20.03 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  12. F12. This SAR was previously reported as a SAR relating to 42,449 shares of the Issuer's common stock at a base price of $10.42 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  13. F13. This SAR was previously reported as a SAR relating to 84,898 shares of the Issuer's common stock at a base price of $10.48 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  14. F14. This SAR was previously reported as a SAR relating to 60,265 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  15. F15. This SAR was previously reported as a SAR relating to 120,530 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  16. F16. This SAR was previously reported as a SAR relating to 100,000 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  17. F17. This SAR was previously reported as a SAR relating to 200,000 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  18. F18. This SAR was previously reported as a SAR relating to 92,528 shares of the Issuer's common stock at a base price of $9.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  19. F19. This SAR was previously reported as a SAR relating to 185,056 shares of the Issuer's common stock at a base price of $9.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  20. F20. This SAR was previously reported as a SAR relating to 96,131 shares of the Issuer's common stock at a base price of $7.81 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  21. F21. This SAR was previously reported as a SAR relating to 192,262 shares of the Issuer's common stock at a base price of $7.78 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  22. F22. The SARs vest in full on March 15 of 2027.
  23. F23. This SAR was previously reported as a SAR relating to 119,225 shares of the Issuer's common stock at a base price of $6.16 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  24. F24. This SAR was previously reported as a SAR relating to 238,450 shares of the Issuer's common stock at a base price of $6.22 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  25. F25. The SARs vest in two equal annual installments on March 15 of 2027 and 2028.
  26. F26. This SAR was previously reported as a SAR relating to 110,193 shares of the Issuer's common stock at a base price of $6.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  27. F27. This SAR was previously reported as a SAR relating to 220,385 shares of the Issuer's common stock at a base price of $6.66 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  28. F28. The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029.
  29. F29. This SAR was previously reported as a SAR relating to 97,561 shares of the Issuer's common stock at a base price of $7.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  30. F30. This SAR was previously reported as a SAR relating to 195,122 shares of the Issuer's common stock at a base price of $7.77 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
Special dividend rate 0.10 shares of Series A Preference Shares per common share Declared on outstanding common shares with record date June 1, 2026
Series A liquidation price $25 per Preferred Share Initial liquidation price of the 9.0% Series A Preference Shares
Series A dividend rate 9.0% fixed rate Fixed Rate Cumulative Perpetual Redeemable Series A Preference Shares
Restricted Share Units P acquired 33,743 units Total RSUs P linked to Series A Preference Shares reported on June 17, 2026
SAR position C (2034) 350,521 underlying Class C shares at $4.2400 Share Appreciation Rights C expiring 2034-03-12 held directly by the reporting person
SAR position A (2034) 170,491 underlying Class A shares at $4.3100 Share Appreciation Rights A expiring 2034-03-12 held directly by the reporting person
Share Appreciation Rights financial
"This share appreciation right award was adjusted as a result of the Dividend."
Share appreciation rights (SARs) are a type of employee award that gives the holder a cash payment or stock equal to the increase in a company's share price over a set period, without requiring the employee to buy shares. For investors, SARs are important because they create a potential future cash outflow or share dilution tied directly to stock performance—like a bonus that grows when the stock goes up—so they affect company cash needs and share count.
Restricted Share Units financial
"Each Restricted Share Unit P represents a right to receive one Series A share."
Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.
anti-dilution provisions financial
"RSUs were adjusted pursuant to the anti-dilution provisions of the incentive plans."
Anti-dilution provisions are contract terms that protect an investor’s percentage ownership when a company issues new shares at a lower price than the investor originally paid. They work like an automatic recalculation of split pieces when a pie gets cut into more slices, preserving the investor’s relative stake and reducing unexpected losses of ownership and voting power, which matters because it affects potential control, future returns, and valuation of an investment.
Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Shares financial
"A 9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Share Dividend was declared."
liquidation price financial
"Series A Preference Shares have an initial liquidation price of $25 per Preferred Share."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did John M Winter report at Liberty Latin America (LILA)?

John M Winter, SVP, CLO and Secretary of Liberty Latin America, reported acquiring 33,743 Restricted Share Units P linked to the company’s Series A Preference Shares on June 17, 2026. These RSUs reflect anti-dilution adjustments to his existing RSU awards.

How are the new Series A RSUs structured for Liberty Latin America (LILA)?

Each Restricted Share Unit P represents a right to receive one Series A Preference Share at settlement. Some RSUs vest in two equal installments on March 15 of 2027 and 2028, while others vest in three equal installments from 2027 through 2029.

What corporate action at Liberty Latin America (LILA) triggered the RSU and SAR adjustments?

Liberty Latin America declared a special dividend of 0.10 Series A Preference Shares on each outstanding common share, payable June 16, 2026 to holders of record June 1, 2026. This Dividend triggered anti-dilution adjustments to all RSUs and share appreciation rights held by Winter.

What are key terms of Liberty Latin America’s Series A Preference Shares (LILA, LILAP)?

The Series A Preference Shares carry a 9.0% fixed rate, are cumulative, perpetual and redeemable, and have an initial $25 liquidation price per share. They trade under the symbol LILAP and were distributed via the 0.10-share special dividend on common stock.

What derivative positions does John M Winter hold in LILA after this report?

Winter continues to hold numerous share appreciation rights over Class A and C common shares, including 350,521 Class C shares at a $4.2400 base price and 170,491 Class A shares at a $4.3100 base price, with expirations extending to March 2036.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WINTER JOHN M

(Last)(First)(Middle)
1550 WEWATTA STREET
SUITE 800

(Street)
DENVER COLORADO 80202

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Liberty Latin America Ltd. [ LILA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP, CLO AND SECRETARY
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Share Units P(1)06/17/2026JV6,298(2)03/15/202703/15/2027Series A Preference Shares6,298(2)$06,298D
Restricted Share Units P(1)06/17/2026JV11,962(2) (3) (3)Series A Preference Shares11,962(2)$011,962D
Restricted Share Units P(1)06/17/2026JV15,483(2) (4) (4)Series A Preference Shares15,483(2)$015,483D
Share Appreciation Rights A$15.1 (5)01/02/2028Class A Common Shares16,951(6)16,951D
Share Appreciation Rights C$14.56 (5)01/02/2028Class C Common Shares34,850(7)34,850D
Share Appreciation Rights A$13.03 (5)05/01/2028Class A Common Shares34,480(8)34,480D
Share Appreciation Rights C$12.41 (5)05/01/2028Class C Common Shares70,889(9)70,889D
Share Appreciation Rights A$13.93 (5)05/01/2029Class A Common Shares33,778(10)33,778D
Share Appreciation Rights C$13.63 (5)05/01/2029Class C Common Shares69,445(11)69,445D
Share Appreciation Rights A$7.29 (5)03/16/2030Class A Common Shares60,702(12)60,702D
Share Appreciation Rights C$7.13 (5)03/16/2030Class C Common Shares124,800(13)124,800D
Share Appreciation Rights A$9.8 (5)03/16/2031Class A Common Shares86,178(14)86,178D
Share Appreciation Rights C$9.6 (5)03/16/2031Class C Common Shares177,179(15)177,179D
Share Appreciation Rights A$9.8 (5)03/16/2031Class A Common Shares143,000(16)143,000D
Share Appreciation Rights C$9.6 (5)03/16/2031Class C Common Shares294,000(17)294,000D
Share Appreciation Rights A$6.78 (5)03/11/2032Class A Common Shares132,315(18)132,315D
Share Appreciation Rights C$6.56 (5)03/11/2032Class C Common Shares272,032(19)272,032D
Share Appreciation Rights A$5.47 (5)03/20/2033Class A Common Shares137,467(20)137,467D
Share Appreciation Rights C$5.3 (5)03/20/2033Class C Common Shares282,625(21)282,625D
Share Appreciation Rights A$4.31 (22)03/12/2034Class A Common Shares170,491(23)170,491D
Share Appreciation Rights C$4.24 (22)03/12/2034Class C Common Shares350,521(24)350,521D
Share Appreciation Rights A$4.68 (25)03/14/2035Class A Common Shares157,575(26)157,575D
Share Appreciation Rights C$4.54 (25)03/14/2035Class C Common Shares323,965(27)323,965D
Share Appreciation Rights A$5.31 (28)03/13/2036Class A Common Shares139,512(29)139,512D
Share Appreciation Rights C$5.29 (28)03/13/2036Class C Common Shares286,829(30)286,829D
Explanation of Responses:
1. Each Restricted Share Unit P ("RSU") represents a right to receive one share of the Issuer's Series A Preference Shares at settlement.
2. In connection with the Dividend (as defined in Remarks), all RSUs with respect to the Issuer's common stock ("Original RSUs") were adjusted pursuant to the anti-dilution provisions of the incentive plans under which the RSU awards held by the reporting person were granted. Each holder of an Original RSU was entitled to receive an RSU with respect to a number of Preferred Shares equal to 0.10 multiplied by the number of shares of common stock underlying the Original RSU, subject to the same terms and conditions as the Original RSU. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3.
3. The RSUs vest in two equal annual installments on March 15 of 2027 and 2028.
4. The RSUs vest in three equal annual installments on March 15 of 2027, 2028 and 2029.
5. The derivative security is fully vested.
6. This share appreciation right award ("SAR") was previously reported as a SAR relating to 11,854 shares of the Issuer's common stock at a base price of $21.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
7. This SAR was previously reported as a SAR relating to 23,708 shares of the Issuer's common stock at a base price of $21.39 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
8. This SAR was previously reported as a SAR relating to 24,112 shares of the Issuer's common stock at a base price of $18.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
9. This SAR was previously reported as a SAR relating to 48,224 shares of the Issuer's common stock at a base price of $18.24 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
10. This SAR was previously reported as a SAR relating to 23,621 shares of the Issuer's common stock at a base price of $19.91 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
11. This SAR was previously reported as a SAR relating to 47,242 shares of the Issuer's common stock at a base price of $20.03 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
12. This SAR was previously reported as a SAR relating to 42,449 shares of the Issuer's common stock at a base price of $10.42 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
13. This SAR was previously reported as a SAR relating to 84,898 shares of the Issuer's common stock at a base price of $10.48 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
14. This SAR was previously reported as a SAR relating to 60,265 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
15. This SAR was previously reported as a SAR relating to 120,530 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
16. This SAR was previously reported as a SAR relating to 100,000 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
17. This SAR was previously reported as a SAR relating to 200,000 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
18. This SAR was previously reported as a SAR relating to 92,528 shares of the Issuer's common stock at a base price of $9.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
19. This SAR was previously reported as a SAR relating to 185,056 shares of the Issuer's common stock at a base price of $9.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
20. This SAR was previously reported as a SAR relating to 96,131 shares of the Issuer's common stock at a base price of $7.81 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
21. This SAR was previously reported as a SAR relating to 192,262 shares of the Issuer's common stock at a base price of $7.78 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
22. The SARs vest in full on March 15 of 2027.
23. This SAR was previously reported as a SAR relating to 119,225 shares of the Issuer's common stock at a base price of $6.16 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
24. This SAR was previously reported as a SAR relating to 238,450 shares of the Issuer's common stock at a base price of $6.22 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
25. The SARs vest in two equal annual installments on March 15 of 2027 and 2028.
26. This SAR was previously reported as a SAR relating to 110,193 shares of the Issuer's common stock at a base price of $6.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
27. This SAR was previously reported as a SAR relating to 220,385 shares of the Issuer's common stock at a base price of $6.66 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
28. The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029.
29. This SAR was previously reported as a SAR relating to 97,561 shares of the Issuer's common stock at a base price of $7.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
30. This SAR was previously reported as a SAR relating to 195,122 shares of the Issuer's common stock at a base price of $7.77 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
Remarks:
On May 21, 2026, the Issuer announced that an authorized committee of the Issuer's board of directors declared a special dividend on each of its outstanding common shares payable on June 16, 2026 to all holders of record as of 5:00 p.m., New York City time, on June 1, 2026 consisting of a special dividend of 0.10 shares of newly issued 9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Shares (the "Series A Preference Shares"), having an initial liquidation price of $25 per Preferred Share (the "Dividend"). The trading symbols for the Issuer's classes of common shares are LILA, LILAB, and LILAK, and the trading symbol for the Issuer's Series A Preference Shares is LILAP.
/s/ John M. Winter07/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)